Why Will Spark The Next Run With Hepion Pharmaceuticals, Inc. (HEPA) Shares?

Facebook
Twitter
WhatsApp

Hepion Pharmaceuticals, Inc. (HEPA) has seen some recent activity in the marketplace and its stock finished trading at $3.2600 yesterday. People are starting to take interest of HEPA as the stock traded as high as $3.4226 and as low as $3.2100 in the last trading session.

Hepion Pharmaceuticals, Inc. (HEPA) average trading volume is 393.39K. However, in the last trading session Hepion Pharmaceuticals, Inc. (HEPA) traded 79,920 shares. The 1st downside support level on HEPA is $3.08 and the 1st resistance level on HEPA is $4.63. HEPA 50 day moving average is $3.2536 and HEPA two hundred day moving average is $2.8917.

Hepion Pharmaceuticals, Inc. (HEPA) most current performance has been specified by the recent movement in HEPA stock. HEPA has performed 5.50% over the past 30 days, HEPA has performed -22.57% over the past quarter and HEPA has shown 2.84% over the past year. Hepion Pharmaceuticals, Inc. (HEPA) has a 1 year range of $1.0000 to $8.3500. Hepion Pharmaceuticals, Inc. (HEPA) is trading 226.00% from its 1 year low and -60.96% from its 1 year high. Hepion Pharmaceuticals, Inc. (HEPA) is indicating a 5.43% short float indicating the quantity short in the float.

HEPA has 9.03M shares outstanding and 9.02M shares in the float. Hepion Pharmaceuticals, Inc. (HEPA) currently has a market cap of $28.88M and income of -12.90M. The EPS next quarter for HEPA is -0.51 and projected EPS next year is 18.30%. The market cap of Hepion Pharmaceuticals, Inc. (HEPA) at $28.88M represents how many People own shares of HEPA and is calculated off the last price ($3.2600) of HEPA and the quantity of shares outstanding (9.03M) with Hepion Pharmaceuticals, Inc. (HEPA).

Hepion Pharmaceuticals, Inc. (HEPA) has aggregate cash (mrq) of 17.56M, aggregate cash per share (mrq) of 1.95, aggregate debt of HEPA stands at 869.45k and aggregate debt/equity (mrq) is 4.75. . Hepion Pharmaceuticals, Inc. (HEPA) operational cash flow (ttm) is -12.03M, HEPA leveraged free cash flow (ttm) is -6.62M.

HEPA is trading -1.50% below (bearish) its SMA20, -1.47% below (bearish) its SMA50 and 5.62% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...